Title |
Effects of Prolylendopeptidase Inhibitor Benzyloxycarbonyl-Methionyl-2(S)-Cyanopyrrolidine on Experimental Depressive Syndrome Development in Rats
|
---|---|
Published in |
Bulletin of Experimental Biology and Medicine, June 2009
|
DOI | 10.1007/s10517-009-0458-6 |
Pubmed ID | |
Authors |
N. N. Khlebnikova, N. A. Krupina, N. G. Bogdanova, N. N. Zolotov, G. N. Kryzhanovskii |
Abstract |
Model of experimental depressive syndrome in rats induced by repeated systemic injection of proneurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine showed that chronic injection of prolylendopeptidase inhibitor benzyloxycarbonyl-methionyl-2(S)-cyanopyrrolidine 30 min before pro-neurotoxin injection prevents the development of a number of depressive syndrome symptoms such as behavioral despair and biorhythmic disorders in forced swimming test, precludes the increase in anxiety-phobic level, prevents reduction of relative thymus mass. These results indicate that benzyloxycarbonyl-methionyl-2(S)-cyanopyrrolidine possesses antidepressant, anxiolytic, and/antistress properties. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 7 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 2 | 29% |
Researcher | 2 | 29% |
Other | 1 | 14% |
Student > Master | 1 | 14% |
Lecturer > Senior Lecturer | 1 | 14% |
Other | 0 | 0% |
Readers by discipline | Count | As % |
---|---|---|
Neuroscience | 2 | 29% |
Psychology | 1 | 14% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 14% |
Medicine and Dentistry | 1 | 14% |
Chemistry | 1 | 14% |
Other | 0 | 0% |
Unknown | 1 | 14% |